
Immunogenicity and safety of a combined measles, mumps, rubella and varicella live vaccine (ProQuad®) administered concomitantly with a booster dose of a hexavalent vaccine in 12-23-month-old infants
Keywords: ClinicalTrials.gov NCT: 00432042; DTaP; diphtheria, tetanus, acellular pertussis; DTaP-HBs-IPV//Hib; diphtheria, tetanus, acellular pertussis, hepatitis B recombinant (adsorbed), inactivated poliomyelitis virus and adsorbed conjugated Haemophilus influenz